AP Enterprise: Church of famed revival struggles Chambersburg Public Opinion Fri, 30 Mar 2012 01:24 AM PDT PENSACOLA, Fla.â€"For years starting in the mid-1990s, millions from around the globe visited a humble church in Florida s Panhandle for lively Pentecostal revival services where believers flocked on stage to be healed by God for cancer, addiction and broken hearts. | MANVILLE: Two youngsters compete in Philadelphia gym meet The Manville News Fri, 30 Mar 2012 01:16 AM PDT On Feb. 25, Brooke Hoodja competed in Philadelphia at the Pink Invitational, a meet organized to help enable Unite for HER assist women affected by breast cancer and to provide wellness education materials. | Drew softball team playing April 3 to help beat cancer Madison Eagle Fri, 30 Mar 2012 01:11 AM PDT MADISON â€" The Drew University softball team will host its first annual “StrikeOut Cancer Day†on Tuesday, April 3, when the Lady Rangers will host the Stevens Institute of Technology team from Hoboken | Shaving heads to fund cancer research The Daily Reflector Fri, 30 Mar 2012 01:09 AM PDT East Carolina University student Sarah Swaim, 22, is a year behind in her studies due to complications from cancer treatment. She plans to be back in the classroom this summer. | March 30, 2012 Dunwoody Crier Fri, 30 Mar 2012 01:05 AM PDT The Cancer Support Community and its network of affiliates across the country have offered support, education and hope to peopl... | Free colon cancer screenings in S. Illinois WPSD Local 6 Paducah Fri, 30 Mar 2012 01:01 AM PDT Prevent colon cancer! A number of locations in Southern Illinois will be handing out free colon cancer take home tests from 11:00 a.m. to 1:00 p.m. Click on the story to see where you can get yours! | Roche to file T-DM1 breast cancer drug on good data Reuters via Yahoo! News Fri, 30 Mar 2012 00:59 AM PDT ZURICH (Reuters) - Roche said patients with an aggressive type of breast cancer lived longer after taking its experimental "armed antibody" drug without the disease worsening than those on a mix of GlaxoSmithKline drug Tykerb and Roche's Xeloda. The positive results from the first Phase III trial of the medicine - dubbed T-DM1 - clears the way for it to be submitted to European and U.S ... | | |
|
No comments:
Post a Comment